Is Belumosudil a domestic drug or an imported drug?

The original drug Belumosudil Tablets (Belumosudil) was developed by an international pharmaceutical company, and it is an imported drug worldwide. In the domestic market, the imported original drug is marketed under the name Besudil Mesylate Tablets (REZUROCK). It is mainly used for the treatment of patients with chronic graft-versus-host disease (cGvHD) and has been included in the scope of medical insurance. When imported drugs are sold domestically, they maintain the same ingredients and dosage specifications as international original drugs to ensure that their efficacy and safety meet international standards. At the same time, they have been approved by the domestic Food and Drug Administration and obtained legal marketing permission.

Currently, no generic drugs have been approved in China, so the domestic version is not yet on the market. Generic drugs have been released in overseas markets, such as Besudil produced by Lucius Pharmaceutical Factory in Laos. Its drug ingredients are basically the same as the original drug and the price is lower, providing a viable option for patients with limited financial conditions. Compared with imported original drugs, the clinical efficacy and pharmacological properties of generic drugs are highly consistent, but they have more advantages in price and accessibility, and are especially suitable for cGvHD patients who require long-term maintenance treatment.

It is very important for patients to understand the import properties and domestic and international supply of Besudil. Imported original drugs have guaranteed efficacy, quality control and safety, but are relatively expensive; while generic drugs, although low in price, are not yet available in the country and must be obtained through overseas channels, subject to policy and logistics restrictions. Imported original drugs marketed in China are included in medical insurance, allowing more patients to afford long-term treatment, and also promoting the popularization of new immune-targeted drugs in the country.

Generally speaking, Besudil is an imported original drug in China, and domestic generic drugs have not yet been launched. With the promotion of clinical applications and the advancement of generic drug research and development, patients may have more affordable and accessible treatment options in the future. They can enjoy the high-quality guarantee of imported drugs and reduce treatment costs through generic drugs.

Reference: https://www.drugs.com/pro/rezurock.html